Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 13.
doi: 10.1515/cclm-2020-1877. Online ahead of print.

Role of ACE2 polymorphism in COVID-19: impact of age

Sadra Mohaghegh  1 , Parisa Motie  1 , Saeed Reza Motamedian  1
Affiliations

Role of ACE2 polymorphism in COVID-19: impact of age

Sadra Mohaghegh et al. Clin Chem Lab Med. .

Abstract

More than 2 million people have died as a result of the COVID-19 outbreak. Angiotensin-converting enzyme 2 (ACE2) is a counter-regulatory enzyme that converts angiotensin-2 to Ang-(1-7) form in the renin-angiotensin system. Several studies have been analyzed the correlation between ACE2 and COVID-19. Indeed, ACE2/Ang (1-7) system protects the lung against acute respiratory distress syndrome by its anti-inflammatory/anti-oxidant function. However, SARS-Cov-2 can use ACE2 for host cell entry. Expression of ACE2 can be altered by several factors, including hypertension, diabetes and obesity, which also could increase the severity of COVID-19 infection. Besides, since androgens increase the expression of ACE-2, males are at higher risks of COVID-19 infection. Although reported statistics showed a significantly different infection risks of COVID-19 between adults and children, the reason behind the different responses is still unclear. This review proposes the effect of ACE polymorphism on the severity of SARS-COV-2 induced pneumonia. The previous meta-analysis regarding the effect of ACE polymorphism on the severity of pneumonia showed that polymorphism only affects the adult's illness severity and not the children. Two recent meta-analyses examined the effect of ACE polymorphism on the prevalence and mortality rate of COVID-19 and reported contradicting results. Our opinion paper suggests that the effect of ACE polymorphism on the severity of COVID-19 depends on the patients age, same as of the pneumonia.

Keywords: COVID-19; angiotensin-converting enzyme; plasma proteins; polymorphism.

PubMed Disclaimer

Comment in

References

    1. Young, MJ, Clyne, CD, Chapman, KE. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2. J Endocrinol 2020;247:R45–62. https://doi.org/10.1530/joe-20-0260.
    1. Lanza, K, Perez, LG, Costa, LB, Cordeiro, TM, Palmeira, VA, Ribeiro, VT, et al.. COVID-19: the renin-angiotensin system imbalance hypothesis. Clin Sci (Lond) 2020;134:1259–64. https://doi.org/10.1042/cs20200492.
    1. Pal, R, Bhansali, A. COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract 2020;162:108132. https://doi.org/10.1016/j.diabres.2020.108132.
    1. Hoffmann, M, Kleine-Weber, H, Schroeder, S, Krüger, N, Herrler, T, Erichsen, S, et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271–80. https://doi.org/10.1016/j.cell.2020.02.052.
    1. Lu, R, Zhao, X, Li, J, Niu, P, Yang, B, Wu, H, et al.. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565–74. https://doi.org/10.1016/s0140-6736(20)30251-8.

LinkOut - more resources